DaVita Inc.

94.63-4.16-4.21%Vol 699.27K1Y Perf -19.12%
May 18th, 2022 15:57 DELAYED
BID94.60 ASK94.65
Open97.90 Previous Close98.79
Pre-Market- After-Market-
 - -%  - -
Target Price
125.33 
Analyst Rating
Hold 2.83
Potential %
32.43 
Finscreener Ranking
+     38.52
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
★★     46.56
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
★★+     49.76
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
0.59 
Earnings Rating
Sell
Market Cap8.95B 
Earnings Date
5th May 2022
Alpha0.00 Standard Deviation0.10
Beta1.13 

Today's Price Range

94.3997.90

52W Range

94.38136.48

5 Year PE Ratio Range

11.8089.60

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-3.35%
1 Month
-17.34%
3 Months
-14.46%
6 Months
-2.82%
1 Year
-19.12%
3 Years
100.67%
5 Years
54.12%
10 Years
144.50%

TickerPriceChg.Chg.%
DVA94.63-4.1600-4.21
AAPL140.44-8.8050-5.90
GOOG2 246.63-87.4000-3.74
MSFT253.88-12.3200-4.63
XOM90.64-1.4750-1.60
WFC42.11-1.6050-3.67
JNJ175.43-3.3900-1.90
FB191.92-10.7000-5.28
GE75.02-1.3800-1.81
JPM119.64-2.5400-2.08
Financial StrengthValueIndustryS&P 500US Markets
1.20
1.30
0.93
14.10
5.80
Leverage Ratio 17.40
ProfitabilityValueIndustryS&P 500US Markets
28.20
14.60
20.50
10.90
9.67
RevenueValueIndustryS&P 500US Markets
11.62B
122.79
0.88
-3.80
Earnings HistoryEstimateReportedSurprise %
Q01 20221.851.61-12.97
Q04 20211.802.0212.22
Q03 20212.212.366.79
Q02 20212.142.6423.36
Q01 20211.802.0916.11
Q04 20201.851.67-9.73
Q03 20201.491.8020.81
Q02 20201.291.9551.16
Earnings Per EndEstimateRevision %Trend
6/2022 QR2.10-0.47Negative
9/2022 QR1.82-15.35Negative
12/2022 FY7.79-4.30Negative
12/2023 FY10.383.28Positive
Next Report Date-
Estimated EPS Next Report1.85
Estimates Count3
EPS Growth Next 5 Years %10.60
Volume Overview
Volume699.27K
Shares Outstanding94.60K
Shares Float58.09M
Trades Count15.19K
Dollar Volume66.50M
Avg. Volume694.20K
Avg. Weekly Volume729.40K
Avg. Monthly Volume679.41K
Avg. Quarterly Volume673.78K

DaVita Inc. (NYSE: DVA) stock closed at 98.79 per share at the end of the most recent trading day (a -1.11% change compared to the prior day closing price) with a volume of 957.60K shares and market capitalization of 8.95B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 67000 people. DaVita Inc. CEO is Javier J. Rodriguez.

The one-year performance of DaVita Inc. stock is -19.12%, while year-to-date (YTD) performance is -13.16%. DVA stock has a five-year performance of 54.12%. Its 52-week range is between 94.38 and 136.48, which gives DVA stock a 52-week price range ratio of 0.59%

DaVita Inc. currently has a PE ratio of 11.90, a price-to-book (PB) ratio of 11.22, a price-to-sale (PS) ratio of 0.81, a price to cashflow ratio of 5.10, a PEG ratio of 2.32, a ROA of 5.35%, a ROC of 8.72% and a ROE of 89.32%. The company’s profit margin is 9.67%, its EBITDA margin is 20.50%, and its revenue ttm is $11.62 Billion , which makes it $122.79 revenue per share.

Of the last four earnings reports from DaVita Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.85 for the next earnings report. DaVita Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for DaVita Inc. is Hold (2.83), with a target price of $125.33, which is +32.43% compared to the current price. The earnings rating for DaVita Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DaVita Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DaVita Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 9.93, ATR14 : 3.71, CCI20 : -128.14, Chaikin Money Flow : -0.08, MACD : -3.91, Money Flow Index : 35.61, ROC : -8.84, RSI : 32.01, STOCH (14,3) : 14.57, STOCH RSI : 0.00, UO : 45.86, Williams %R : -85.43), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DaVita Inc. in the last 12-months were: James O. Hearty (Option Excercise at a value of $149 491), Joel Ackerman (Option Excercise at a value of $20 000 008), Joel Ackerman (Sold 75 520 shares of value $9 920 292 ), Michael David Staffieri (Option Excercise at a value of $2 429 373), Pamela M. Arway (Sold 1 190 shares of value $141 116 ), Paula A. Price (Sold 1 490 shares of value $184 355 ), Phyllis R. Yale (Option Excercise at a value of $834 145), Phyllis R. Yale (Sold 5 048 shares of value $627 601 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (16.67 %)
1 (14.29 %)
1 (14.29 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
4 (66.67 %)
5 (71.43 %)
5 (71.43 %)
Moderate Sell
1 (16.67 %)
1 (14.29 %)
1 (14.29 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
2.83
Hold
2.86
Hold
2.86

DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government ( primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

CEO: Javier J. Rodriguez

Telephone: +1 720 631-2100

Address: 2000 16th Street, Denver 80202, CO, US

Number of employees: 67 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

63%37%

Bearish Bullish

59%41%

News

Stocktwits